Akebia Therapeutics stock price
아케비아 테라퓨틱스NASDAQ:AKBA · Nasdaq · HealthcareToday's signals · MACD bullish cross
Signal details →Akebia Therapeutics last closed at $0.8650 (-0.69%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -7.9×. Its overall grade ranks 698 of 739 stocks in Healthcare.
About this company
Akebia Therapeutics last closed at $0.8650 (-0.69%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall F · 698/739
Valuation grade B-
Related stocks
- Otsuka HoldingsCustomer
아케비아의 일본·미국 상업화 파트너로 치료제 판매와 로열티에 영향
- Keryx BiopharmaceuticalsRelated theme
아케비아가 인수해 보유한 레나젤(Renvela)·Auryxia 관련 사업과 직접 연결
- FDARelated theme
신약 허가·라벨 확장·안전성 이슈가 매출과 가치에 직접 영향
About Akebia Therapeutics
- What technical signals does Akebia Therapeutics (AKBA) have?
- Akebia Therapeutics current technical signals: MACD bullish cross.
- Is Akebia Therapeutics a cup-and-handle pattern?
- No. Akebia Therapeutics has no valid Cup signal right now.
- What published figures are available for Akebia Therapeutics?
- Market cap: $229.54M. Trailing 12 months PER: -7.9×. Latest quarter PBR: 9.32×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Akebia Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).